Concurrent identification of Natural Antibiotics-Producing Gene Clusters and Culture Conditions
Award amount
$149,993Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- Carrera Bioscience Inc.
- Proposal award date
- 2015-09-09
- Contract end date
- 2017-03-18
- UEI
- FQ2XMQK6JN31
- Solicitation number
- 2015.2
- Topic code
- CBD152-004
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Specific Detection of Hepatitis B Virus cccDNA from Patient Sera Plasma
- Virus specific diagnosis of hepatitis infection using isothermal amplification in resource poor settings
- Biomimetic Material Solutions for the Stabilization of Labile Reagents
- Virus specific diagnosis of hepatitis infection using isothermal amplification in resource poor settings
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes
- Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes
- Exploiting Microbiome and Synthetic Biology to Discover and Produce Naturally Occurring Antibiotics
Research funding history
5 SBIR/STTR records share this UEI (2015–2016). Reported award amounts total $1,204,492. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense